Search

Olof Bengtsson

Dapagliflozin across the range of ejection fraction in patients with heart failure: a patient-level, pooled meta-analysis of DAPA-HF and DELIVER
Design and Analysis of Studies Based on Hierarchical Composite Endpoints: Insights from the DARE-19 Trial
Power and sample size calculation for the win odds test: application to an ordinal endpoint in COVID-19 trials
Dapagliflozin and Recurrent Heart Failure Hospitalizations in Heart Failure With Reduced Ejection Fraction: An Analysis of DAPA-HF
Adjusted win ratio with stratification: Calculation methods and interpretation

Published with Wowchemy — the free, open source website builder that empowers creators.